- Home
- /Succinylacetone
Succinylacetone
Measures succinylacetone in blood to screen for tyrosinemia type 1.
Why This Biomarker Matters
Elevated succinylacetone indicates tyrosinemia type 1, a serious genetic disorder. Newborn detection enables early dietary and medical treatment preventing liver failure and kidney disease.
Understanding Your Results
Normal Range
0.3 umol/L
Overview
Succinylacetone is a toxic compound produced in tyrosinemia type 1, a rare genetic metabolic disorder affecting amino acid processing. This newborn screening test uses bloodspot analysis to measure succinylacetone levels, as elevated levels indicate impaired liver enzyme function. Tyrosinemia type 1 causes progressive liver disease, kidney dysfunction, neurological problems, and increased cancer risk without treatment. Early detection through newborn screening allows prompt initiation of dietary restriction and medications to prevent liver failure, kidney damage, and other serious complications.
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
75079-4Primary53231-730483-238912-242677-574957-2Available Lab Tests
Order tests that measure this biomarker